🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being conducted to compare the pharmacokinetics, safety, and p...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2025-05-29
Trial ID
NCT07152288
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of HSK3929...
Status
Completed
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2025-02-13
Trial ID
NCT06799546
Treatments Being Tested
To evaluate the absorption, metabolism and excretion in healthy Chinese mal...
Status
Completed
Location
The Second Affiliated Hospital of Soochow University
Start Date
2024-09-09
Trial ID
NCT06852092
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of HSK39297 tablets i...
Status
Completed
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2025-05-12
Trial ID
NCT07052838
Treatments Being Tested
This is a Phase II, multicenter, open-label study. Eligible subjects who ha...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2025-08-25
Trial ID
NCT07616700
Treatments Being Tested
This is a multicenter, open-label study to evaluate the long-term safety, t...
Status
Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2025-01-03
Trial ID
NCT06745622
Treatments Being Tested
Evaluate the efficacy and safety of HSK39297 tablets in patients with prima...
Status
Recruiting
Location
Huangshan City People's Hospital
Start Date
2026-04-07
Trial ID
NCT07390123
Evaluate the efficacy and safety of HSK39297 tablets in patients with prima...
Status
Completed
Location
Peking University First Hospital
Start Date
2024-10-12
Trial ID
NCT06670352
Treatments Being Tested
This is a multicenter, randomized, open-label phase 2 study. Adult Patients...
Status
Completed
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2024-07-17
Trial ID
NCT06561841
Treatments Being Tested
This is a Phase I, randomized, subject-blinded, placebo controlled study to...
Status
Completed
Location
Beijing Tongren Hospital
Start Date
2023-12-25
Trial ID
NCT06350279
Treatments Being Tested